Jul 26, 2007 by Ryan FuhrmannBrunswick Still Not Above WaterThe boat engine maker cuts production and guidance.
Jul 25, 2007 by Ryan FuhrmannThe Latest Procedure From Quest DiagnosticsIt took a hit earlier this year, but the lab testing firm isn't down for the count.
Jul 25, 2007 by Ryan FuhrmannCheesecake Factory's Tasty ProspectsNear-term costs continue to worry investors, but Cheesecake Factory is here to stay.
Jul 23, 2007 by Ryan FuhrmannBoston Scientific Still DrowsyFacing continued top-line weakness, the company may have to cut costs.
Jul 23, 2007 by Ryan FuhrmannWachovia Is One Big DealWachovia snapped up one rival and is still digesting another.
Jul 23, 2007 by Ryan FuhrmannBank of America Is OutbankedMighty B of A was outbanked during the second quarter, but help is on the horizon.
Jul 20, 2007 by Ryan FuhrmannStryker Does a Body GoodThe orthopedics company continues its double-digit growth in an industry with a bright future.
Jul 20, 2007 by Ryan FuhrmannMohawk Gets a TrimMohawk got a haircut today, but expect it to outgrow any industry challenges.
Jul 20, 2007 by Ryan FuhrmannWhirlpool Continues to Rinse MaytagCost-cutting moves are benefiting Whirlpool, but they will soon run their course.
Jul 19, 2007 by Ryan FuhrmannGive Me an I ... Give Me an I ... Give Me an IBMGlobal exposure is boosting Big Blue.
Jul 19, 2007 by Ryan FuhrmannSherwin-Williams' BrushbackThe company is doing well while dealing with slower homebuilding and lead-paint litigation.
Jul 19, 2007 by Ryan FuhrmannAllstate: Still an All-Star?Non-operating gains help Allstate post a quarterly earnings gain.
Jul 18, 2007 by Ryan FuhrmannFurther Savings for Regions FinancialRegions Financial continues to wring savings from a recent merger.
Jul 18, 2007 by Ryan FuhrmannWells Fargo Makes CentsIs double-digit growth synonymous with this bank?
Jul 18, 2007 by Ryan FuhrmannTime to Turn the KeyCorp?Is a re-emphasis on commercial banking paying enough dividends at KeyCorp?
Jul 18, 2007 by Ryan FuhrmannPfizer Prepares for L-DayWill Pfizer be able to offset the looming loss of Lipitor?
Jul 18, 2007 by Ryan FuhrmannMore M&A for M&IMarshall & Ilsey's got plenty of merger-and-acquisition activity ahead.
Jul 17, 2007 by Ryan FuhrmannDiagnosing J&J's Product DiversityJ&J's blues may indicate trouble ahead for competitors.
Jul 17, 2007 by Ryan FuhrmannConcentrated Results at Coca-ColaCoke is close, but still hasn't regained its status as a consistent grower.
Jul 16, 2007 by Ryan FuhrmannFool on the Street: The Straight Scoop From ScottsScotts is an interesting small-cap play on the domestic lawn and garden industry.
